This inventor holds 1 USPTO granted patent, plus 2 CIPO patents and 1 EPO patent. Top assignee: Immunext, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: The Innovations of Robert George Edward Holgate
Introduction
Robert George Edward Holgate is a notable inventor based in Royston, GB. He has made significant contributions to the field of immunotherapy, particularly through his innovative patent. His work focuses on enhancing the effectiveness and safety of treatments for human health.
Latest Patents
Holgate holds a patent titled "ANTI-CD154 ANTIBODY HAVING IMPROVED BINDING, FUNCTIONAL AND SAFETY CHARACTERISTICS AND USE IN HUMAN IMMUNOTHERAPY." This patent represents a crucial advancement in the development of immunotherapeutic agents, showcasing his commitment to improving patient outcomes.
Career Highlights
Holgate is associated with Immunext, Inc., where he applies his expertise in immunology and antibody development. His work at the company has positioned him as a key player in the advancement of therapeutic solutions.
Collaborations
He collaborates with talented individuals such as Arron Hearn and Jay Rothstein, contributing to a dynamic team focused on innovative research and development in the field of immunotherapy.
Conclusion
Robert George Edward Holgate's contributions to immunotherapy through his patent and collaborative efforts highlight his role as an influential inventor in the medical field. His work continues to pave the way for advancements that can significantly impact human health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile